Medical Condition News

RSS

The effect of COVID-19 on the lung function of young adults

Researchers evaluate whether SARS-CoV-2 infection has a negative impact on lung function in young adults who experienced mild to moderate COVID-19.

3 Apr 2022

COVID-19 vaccine can cause temporary delay in menstruation

Both the first and second doses of COVID-19 vaccines were related to a modest delay in menstruation.

3 Apr 2022

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

Scientists discuss the pathogenic characteristics of SARS-CoV-2 and available therapeutic interventions for treating COVID-19.

3 Apr 2022

Global study demonstrates some benefits of flu vaccine in people with heart failure

People with heart failure who received an annual flu shot had lower rates of pneumonia and hospitalization on a year-round basis and a reduction in major cardiovascular events during peak flu season, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

3 Apr 2022

Personalized nutrition education at a grocery store improves adherence to DASH diet

People who received personalized nutrition education in a series of sessions conducted at their regular grocery store significantly improved their adherence to the Dietary Approaches to Stop Hypertension (DASH) diet, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

3 Apr 2022

Investigational drug vupanorsen reduces non-HDL cholesterol by up to 28%

The investigational drug vupanorsen reduced total levels of non-high-density lipoprotein (non-HDL) cholesterol by up to 28% in patients with high cholesterol who were already taking a cholesterol-lowering statin medication, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

3 Apr 2022

Multi-mineral supplement could help reduce downstream consequences of fatty liver disease

Results from a preclinical study add new evidence that a multi-mineral dietary supplement known as Aquamin could be a simple and effective way to reduce the long-term health consequences of non-alcoholic fatty liver disease.

3 Apr 2022

Experimental siRNA therapy reduces a key driver of heart disease risk by up to 98%

Findings from a new Cleveland Clinic-led phase 1 trial show that an experimental "gene silencing" therapy reduced blood levels of lipoprotein(a), a key driver of heart disease risk, by up to 98%.

3 Apr 2022

First practical guide on the use of digital devices for heart rhythm and rate monitoring published

Who should monitor their heart rate and rhythm and which device should they use? Find out in an international consensus document published today in EP Europace, a journal of the European Society of Cardiology (ESC) and presented at EHRA 2022, a scientific congress of the ESC.

3 Apr 2022

Recommendations to prevent, manage interference in patients with implanted cardiac devices

Recommendations on the prevention and management of interference caused by medical procedures in patients with implanted electronic cardiac devices is published today in EP Europace, a journal of the European Society of Cardiology and presented at EHRA 2022, a scientific congress of the ESC.

3 Apr 2022

Cedars-Sinai’s Los Angeles Barbershop Blood Pressure Study delivers new insights

The Los Angeles Barbershop Blood Pressure Study is delivering cutting-edge insights more than four years after the study results were published in The New England Journal of Medicine.

2 Apr 2022

New evidence on how salt reduction can benefit heart failure patients

For the past century people with weak hearts have been told to lower their salt intake, but until now there has been little scientific evidence behind the recommendation.

2 Apr 2022

High caffeine consumption induces ventricular tachyarrhythmias in rats

The Food and Drug Administration recommends healthy adults not exceed 400 milligrams (mg) of caffeine- approximately four cups of brewed coffee- a day.

2 Apr 2022

Virtual population used to replicate a clinical trial that examines kidney damage in Black Americans

Researchers have successfully used a virtual population to replicate a clinical trial that examined kidney damage in Black Americans, according to a new study at the University of Mississippi Medical Center in Jackson. John S. Clemmer, PhD, a physiologist and lead author of the study, said his team model used a calcium channel blocker to predict kidney damage.

2 Apr 2022

Study lays the groundwork for development of new treatments for Alzheimer's

It's long been known that brain vessel dysfunction induced by a peptide called amyloid-beta (Aβ) could lead to Alzheimer's disease (AD).

2 Apr 2022

Smokers have lower odds of surviving a heart attack than non-smokers

Smokers have a lower chance of surviving a heart attack than non-smokers, according to new data compiled by researchers at Jordan University of Science and Technology in Irbid.

2 Apr 2022

Experimental drug for hypertrophic cardiomyopathy reduces the need for invasive procedures, trial shows

Findings from a Cleveland Clinic-led clinical trial showed that the use of an experimental drug in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for invasive procedures.

2 Apr 2022

Treating mild hypertension during pregnancy reduces the risk of adverse outcomes

Treating even mildly elevated, or non-severe, blood pressure during pregnancy reduces the risk of adverse pregnancy outcomes and is unlikely to harm the developing baby, according to a study being presented at the American College of Cardiology's (ACC) 71st Annual Scientific Session.

2 Apr 2022

Limiting sodium intake results in improved quality of life for patients with heart failure

Nutrition counseling and strictly limiting salt intake for one year in patients with heart failure resulted in improved quality of life and a slowing in the progression of the disease, but a study presented at the American College of Cardiology's (ACC) 71st Annual Scientific Session found reducing salt intake did not significantly reduce major adverse events or hospitalizations.

2 Apr 2022

Adolescents with severe substance use disorder more likely to report prescription drug misuse in adulthood

While it’s estimated that 1 in 3 Americans will develop a substance use disorder in their lifetime, experts know little about the long-term outcomes for people with substance use disorder symptoms from adolescence through adulthood.

1 Apr 2022

Medical Condition News

The effect of COVID-19 on the lung function of young adults

COVID-19 vaccine can cause temporary delay in menstruation

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

Global study demonstrates some benefits of flu vaccine in people with heart failure

Personalized nutrition education at a grocery store improves adherence to DASH diet

Investigational drug vupanorsen reduces non-HDL cholesterol by up to 28%

Multi-mineral supplement could help reduce downstream consequences of fatty liver disease

Experimental siRNA therapy reduces a key driver of heart disease risk by up to 98%

First practical guide on the use of digital devices for heart rhythm and rate monitoring published

Recommendations to prevent, manage interference in patients with implanted cardiac devices

Cedars-Sinai’s Los Angeles Barbershop Blood Pressure Study delivers new insights

New evidence on how salt reduction can benefit heart failure patients

High caffeine consumption induces ventricular tachyarrhythmias in rats

Virtual population used to replicate a clinical trial that examines kidney damage in Black Americans

Study lays the groundwork for development of new treatments for Alzheimer's

Smokers have lower odds of surviving a heart attack than non-smokers

Experimental drug for hypertrophic cardiomyopathy reduces the need for invasive procedures, trial shows

Treating mild hypertension during pregnancy reduces the risk of adverse outcomes

Limiting sodium intake results in improved quality of life for patients with heart failure

Adolescents with severe substance use disorder more likely to report prescription drug misuse in adulthood

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News